Bain Capital Specialty Finance Inc. (BCSF) 12-Month Stock Forecast & Price Target Cone

Per the Roarable RQD rating, BCSF scores 46 out of 100, grade D, labeled "Roarable Sell — Underperform / Distribution Warning." The five pillars are: Fundamental Cash Engine 10/20 (ROIC 8.8%; FCF yield 4.19%), Whale 13F Flow 7/20 (institutional accumulation and options positioning), Insider Conviction 13/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit 6/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet 10/20 (Altman Z 2.5; Piotroski F 3/9; Debt/Equity 0.5).

Taken together, the pillar scores indicate weakness across most dimensions. The highest-scoring pillar, Insider Conviction at 13/20, is the strongest component, while Macro Regime Fit at 6/20 and Whale 13F Flow at 7/20 are the weakest. For a prospective investor, the practical implications are: the 4.19% FCF yield and 8.8% ROIC provide some cash-generation support, but the Piotroski F-Score of 3/9 signals limited fundamental strength on that framework. The price-to-earnings multiples (7.1 TTM, 6.6 forward) sit at the low end of the source data's range, which may reflect market skepticism rather than a clear discount; the source data does not establish which. The Beta of 1.0 means the rating's macro-fit weakness reflects sector sensitivity rather than unusual volatility. The verdict label itself flags distribution risk, which an investor should weigh against the stock's position near its 52-week low.

Per the SEC financials, net income declined from $123.4M (FY 2023) to $119.4M (FY 2024) and then to $98.8M (FY 2025), while free cash flow moved from $219.3M to $-27.1M before recovering to $29.5M. Per the market data section, gross, operating, and net margins are each reported as 0%, which the source data does not explain; revenue is reported as $0.0M in each period. The market data reports ROIC of 8.8%, and the Roarable RQD rating records an Altman Z-Score of 2.5, a Piotroski F-Score of 3/9, and Debt/Equity of 0.5. Reported debt is N/A across all periods, so balance-sheet leverage cannot be traced to the financials section beyond the Debt/Equity figure.

Per the recent news section, six items were reported, all tagged with a YELLOW signal and a "MARKET WIRE" impact label. Two headlines report BCSF setting a new 12-month or 1-year low (MarketBeat), which corresponds to the 52-week range of $10 - $14.7 and the current price of $10.85. A third headline announces the scheduling of the earnings release for the quarter ended September 30, 2026, a near-term scheduled catalyst. Another headline reports an institutional purchase by Columbus Macro LLC, and a Stock Traders Daily item discusses technical reactions to BCSF trends in macro strategies. Risk watch items include the repeated new-low headlines and the macro-strategy technical discussion. Per the Butterfly Supply-Chain Graph, no proprietary signals are recorded.

• What does BCSF's revenue base consist of, given that revenue and operating income are reported as $0.0M in every period?
• Why are gross, operating, and net margins each reported as 0%, and what income measure underlies the reported net income?
• What is the composition and maturity of the debt position, since reported debt is N/A across all periods?
• What drove the reported decline in net income across FY 2023 through FY 2025, and what explains the swing in free cash flow?
• Does the low P/E multiple reflect the earnings trajectory, the sector, or the distribution warning flagged in the RQD verdict?